
The ROBO Global Healthcare Technology and Innovation ETF (HTEC) has outperformed in 2026 by focusing on specialized healthcare technology sectors like genomics, diagnostics, and medical instruments. Key contributors include Twist Bioscience, Moderna, and Guardant Health, which have shown strong stock gains reflecting a shift from traditional pharma to innovative medical tech. This ETF offers investors a way to diversify portfolios with exposure to early-stage medical breakthroughs without overlapping with broader tech funds. The trend highlights growing opportunities in healthcare innovation beyond legacy pharmaceutical companies.